MyAverix Finance
SHG · Healthcare
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621)
Drug Manufacturers - Specialty & Generic
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $7.24B, P/E ratio is 53.02, net margin is 16.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688621
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) — FAQ
What is Beijing Sun Novo Pharmaceutical Research Co Ltd's market cap?
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) has a reported market cap of $7.24B (data as of 2026-03-29).
What is 688621's P/E ratio?
The price-to-earnings (P/E) ratio for Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) is 53.02 (data as of 2026-03-29).
Does Beijing Sun Novo Pharmaceutical Research Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Beijing Sun Novo Pharmaceutical Research Co Ltd (688621). Check the MyAverix Finance app for the latest dividend data.
What sector is Beijing Sun Novo Pharmaceutical Research Co Ltd in?
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 688621 listed on?
688621 is listed on SHG.
What is Beijing Sun Novo Pharmaceutical Research Co Ltd's net margin?
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) reports a net margin of 16.1% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.